| Dr Jason Tai Pang Lam, MD | |
|
302 California Ave, Suite 103, Wahiawa, HI 96786-1841 | |
| (808) 621-7733 | |
| (808) 621-7799 |
| Full Name | Dr Jason Tai Pang Lam |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 302 California Ave, Wahiawa, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114033040 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QA0505X | Family Medicine - Adult Medicine | MD11212 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wahiawa General Hospital | Wahiawa, HI | Hospital |
| Pali Momi Medical Center | Aiea, HI | Hospital |
| Entity Name | Wahiawa Family Practice Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386753903 PECOS PAC ID: 9537054259 Enrollment ID: O20040220000022 |
News Archive
Pharmasset, Inc., announced today sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 400 mg dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 1 who have not been treated previously. 43 out of 44 (98%) evaluable subjects achieved an SVR12, defined as HCV RNA below the limit of detection (<15 IU/mL) 12 weeks after the completion of treatment.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has entered into an agreement with ForSight Labs, LLC to license certain non-core ophthalmology technology. The technology licensed in this agreement does not include the Company's I-vation™ drug delivery technology. While the license agreement contains an up-front license fee, milestone payments and royalties, specific terms of the agreement were not disclosed.
Profil Institute for Clinical Research, Inc., a company focused on early phase clinical trials for diabetes and obesity, and Florida Hospital, one of nation's largest clinical care providers, announced today a joint venture to establish a state-of-the-art early phase clinical services center for metabolic disease research, including diabetes, obesity and cardiometabolic diseases.
The Pancreatic Cancer Collective, an initiative of the Lustgarten Foundation and Stand Up To Cancer®, announced today the launch of a new PSA campaign.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason Tai Pang Lam, MD 302 California Ave, Suite 103, Wahiawa, HI 96786-1841 Ph: (808) 621-7733 | Dr Jason Tai Pang Lam, MD 302 California Ave, Suite 103, Wahiawa, HI 96786-1841 Ph: (808) 621-7733 |
News Archive
Pharmasset, Inc., announced today sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 400 mg dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 1 who have not been treated previously. 43 out of 44 (98%) evaluable subjects achieved an SVR12, defined as HCV RNA below the limit of detection (<15 IU/mL) 12 weeks after the completion of treatment.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has entered into an agreement with ForSight Labs, LLC to license certain non-core ophthalmology technology. The technology licensed in this agreement does not include the Company's I-vation™ drug delivery technology. While the license agreement contains an up-front license fee, milestone payments and royalties, specific terms of the agreement were not disclosed.
Profil Institute for Clinical Research, Inc., a company focused on early phase clinical trials for diabetes and obesity, and Florida Hospital, one of nation's largest clinical care providers, announced today a joint venture to establish a state-of-the-art early phase clinical services center for metabolic disease research, including diabetes, obesity and cardiometabolic diseases.
The Pancreatic Cancer Collective, an initiative of the Lustgarten Foundation and Stand Up To Cancer®, announced today the launch of a new PSA campaign.
› Verified 3 days ago
Laura Chachula, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1280 Wright Ave, Bldg 680x, Wahiawa, HI 96786 Phone: 808-656-1628 | |
Sara Christensen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 128 Lehua Street, Wahiawa, HI 96786 Phone: -- | |
Mr. Norberto Baysa, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 302 California Ave, Suite 106, Wahiawa, HI 96786 Phone: 808-622-1618 Fax: 808-622-3083 | |
Dr. Hannah E. Aho, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 128 Lehua St, Wahiawa, HI 96786 Phone: 808-621-4355 | |
Dr. Ellen H Sofio, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 302 California Ave, Ste 210, Wahiawa, HI 96786 Phone: 808-291-4274 Fax: 808-622-1808 | |
Dr. Deborah Candace Love, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 302 California Ave Ste 208, Wahiawa, HI 96786 Phone: 808-622-5556 Fax: 808-621-4594 |